American Journal of Preventive Medicine
Volume 35, Issue 6 , Pages 598-601 , December 2008

Gender Difference Among Smoking, Adiponectin, and High-Sensitivity C-Reactive Protein

  • Tiina M. Ahonen, MD

      Affiliations

    • Palokka Health Centre, Central Hospital of Middle Finland, Jyväskylä
    • Corresponding Author InformationAddress correspondence and reprint requests to: Tiina M. Ahonen, MD, Palokka Health Centre, Ritopohjantie 25, 40270, Palokka, Finland
  • ,
  • Hannu J. Kautiainen, BA

      Affiliations

    • Medcare Foundation, Äänekoski, University of Oulu, Oulu
  • ,
  • Sirkka M. Keinänen-Kiukaanniemi, MD, PhD

      Affiliations

    • Department of General Practice, University of Oulu, Oulu
  • ,
  • Esko A. Kumpusalo, MD, PhD

      Affiliations

    • Department of Public Health and Clinical Nutrition University of Kuopio, Kuopio
    • Unit of Family Practice Kuopio University Hospital, Kuopio
  • ,
  • Mauno J. Vanhala, MD, PhD

      Affiliations

    • Unit of General Practice, Central Hospital of Middle Finland, Jyväskylä, Finland
    • Department of Public Health and Clinical Nutrition University of Kuopio, Kuopio
    • Laukaa Health Centre, Laukaa, Finland

References 

  1. Paoletti R, Bolego C, Poli A, Cignarella A. Metabolic syndrome, inflammation and atherosclerosis. Vasc Health Risk Manag. 2006;2:145–152
  2. Chandran M, Phillips SA, Ciaraldi T, Henry RR. Adiponectin: more than just another fat cell hormone?. Diabetes Care. 2003;26:2442–2450
  3. Haverkate F, Thompson SG, Pyke SD, Gallimore JR, Pepys MB. Production of C-reactive protein and risk of coronary events in stable and unstable angina (European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group). Lancet. 1997;349:462–466
  4. Ford ES. Body mass index, diabetes and C-reactive protein among U.S. adults. Diabetes Care. 1999;22:1971–1977
  5. Chiolero A, Faeh D, Paccaud F, Cornuz J. Consequences of smoking for body weight, body fat distribution, and insulin resistance. Am J Clin Nutr. 2008;87:801–809
  6. Yanbaeva DG, Dentener MA, Creutzberg EC, Wesseling G, Wouters EF. Systemic effects of smoking. Chest. 2007;131:1557–1566
  7. Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol. 2006;6:772–783
  8. Han TS, Sattar N, Williams K, Gonzalez-Villalpando C, Lean MEJ, Haffner SM. Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study. Diabetes Care. 2002;25:2016–2021
  9. Ukkola O, Kesäniemi YA. Leptin and high-sensitivity C-reactive protein and their interaction in the metabolic syndrome in middle-aged subjects. Metabolism. 2007;56:1221–1227
  10. Thorand B, Baumert J, Döring A, et al. Sex differences in the relation of body composition to markers of inflammation. Atherosclerosis. 2006;184:216–224
  11. Thorand B, Baumert J, Kolb H, et al. Sex differences in the prediction of type 2 diabetes by inflammatory markers: results from the MONICA/KORA Augsburg case-cohort study, 1984–2002. Diabetes Care. 2007;30:854–860
  12. Snijder MB, Dekker JM, Visser M, et al. Prospective relation of C-reactive protein with type 2 diabetes: response to Han, et al. Diabetes Care. 2003;26:1656–1657author reply 1657–8
  13. Takefuji S, Yatsuya H, Tamakoshi K, et al. Smoking status and adiponectin in healthy Japanese men and women. Prev Med. 2007;45:471–475
  14. Iwashima Y, Katsuya T, Ishikawa K, et al. Association of hypoadiponectinemia with smoking habit in men. Hypertension. 2005;45:1094–1100
  15. Thamer C, Stefan N, Stumvoll M, Häring H, Fritsche A. Reduced adiponectin serum levels in smokers. Atherosclerosis. 2005;179:421–422
  16. Fain JN. Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells. Vitam Horm. 2006;74:443–477
  17. Ludescher B, Najib A, Baar S, et al. Gender specific correlations of adrenal gland size and body fat distribution: a whole body MRI study. Horm Metab Res. 2007;39:515–518
  18. Zamboni M, Zoico E, Scartezzini T, et al. Body composition changes in stable-weight elderly subjects: the effect of sex. Aging Clin Exp Res. 2003;15:321–327
  19. Mayes JS, Watson GH. Direct effects of sex steroid hormones on adipose tissues and obesity. Obes Rev. 2004;5:197–216
  20. Georges E, Mueller WH, Wear ML. Body fat distribution in men and women of the Hispanic health and nutrition examination survey of the U.S.: associations with behavioural variables. Ann Hum Biol. 1993;20:275–291
  21. Daniel M, Martin AD, Faiman C. Sex hormones and adipose tissue distribution in premenopausal cigarette smokers. Int J Obes Relat Metab Disord. 1992;16:245–254
  22. Garcia-Lorda P, Bullo M, Balanza R, Salas-Salvado J. C-reactive protein, adiposity and cardiovascular risk factors in a Mediterranean population. Int J Obes. 2006;30:468–474
  23. Fröhlich M, Sund M, Löwel H, Imhof A, Hoffmeister A, Koenig W. Independent association of various smoking characteristics with markers of systemic inflammation in men: results from a representative sample of the general population (MONICA Augsburg Survey 1994/95). Eur Heart J. 2003;24:1365–1372
  24. Bermudez EA, Rifai N, Buring J, Manson JE, Ridker PM. Interrelationships among circulating Interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women. Arterioscler Thromb Vasc Biol. 2002;22:1668–1673
  25. Fried SK, Bunkin DA, Greenberg AS. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab. 1998;83:847–885

PII: S0749-3797(08)00771-X

doi: 10.1016/j.amepre.2008.09.011

American Journal of Preventive Medicine
Volume 35, Issue 6 , Pages 598-601 , December 2008